Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N Brogden

Showing results (91-100 of 251) with videos related to

Pageof 26
Sort By:
Drugs|October 1, 1991
Naftifine. A review of its antimicrobial activity and therapeutic use in superficial dermatomycosesJ P Monk, R N Brogden
Drugs|March 1, 1991
Quinapril. A review of its pharmacological properties, and therapeutic efficacy in cardiovascular disordersA N Wadworth, R N Brogden
Drugs|October 1, 1989
Mesalazine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in chronic inflammatory bowel diseaseR N Brogden, E M Sorkin
Drugs|November 1, 1987
Encainide. A review of its pharmacological properties and therapeutic efficacyR N Brogden, P A Todd
Drugs|October 1, 1989
Cefixime. A review of its antibacterial activity. Pharmacokinetic properties and therapeutic potentialR N Brogden, D M Campoli-Richards
Drugs|June 1, 1987
Sulbactam/ampicillin. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic useD M Campoli-Richards, R N Brogden
Drugs|September 1, 1991
Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disordersA N Wadworth, D Murdoch, R N Brogden
Drugs|March 1, 1990
Buserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical profileR N Brogden, M M Buckley, A Ward
Drugs|December 1, 1985
Norfloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic useB Holmes, R N Brogden, D M Richards
Drugs|January 1, 1995
Torasemide. An update of its pharmacological properties and therapeutic efficacyC J Dunn, A Fitton, R N Brogden
Pageof 26

Showing results (91-100 of 251) with videos related to

Sort By:
Pageof 26
Drugs|October 1, 1991
Naftifine. A review of its antimicrobial activity and therapeutic use in superficial dermatomycosesJ P Monk, R N Brogden
Drugs|March 1, 1991
Quinapril. A review of its pharmacological properties, and therapeutic efficacy in cardiovascular disordersA N Wadworth, R N Brogden
Drugs|October 1, 1989
Mesalazine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in chronic inflammatory bowel diseaseR N Brogden, E M Sorkin
Drugs|November 1, 1987
Encainide. A review of its pharmacological properties and therapeutic efficacyR N Brogden, P A Todd
Drugs|October 1, 1989
Cefixime. A review of its antibacterial activity. Pharmacokinetic properties and therapeutic potentialR N Brogden, D M Campoli-Richards
Drugs|June 1, 1987
Sulbactam/ampicillin. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic useD M Campoli-Richards, R N Brogden
Drugs|September 1, 1991
Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disordersA N Wadworth, D Murdoch, R N Brogden
Drugs|March 1, 1990
Buserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical profileR N Brogden, M M Buckley, A Ward
Drugs|December 1, 1985
Norfloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic useB Holmes, R N Brogden, D M Richards
Drugs|January 1, 1995
Torasemide. An update of its pharmacological properties and therapeutic efficacyC J Dunn, A Fitton, R N Brogden
Pageof 26